Table 4.

Investigations and diagnoses of admitted patients.

Investigations and Results	Number of Patients
Umbilical swab
MRSA *	3 (2.7%)
Staphylococcus aureus	1 (0.92%)
Klebsiella	2 (1.85%)
Nasal swab
Staphylococcus aureus	20 (18.5%)
Proteus	2 (1.85%)
Group D Streptococcus	1 (0.92%)
Ophthalmic swab—Staphylococcus aureus	2 (1.85%)
Urine culture
Klebsiella	3 (2.7%)
Escherichia coli	4 (3.7%)
Positive COVID-19 Antigen/PCR **	4 (3.7%)
Positive Type A Influenza Antigen	1 (0.92%)
Positive Respiratory Syncytial Virus (RSV) Antigen	1 (0.92%)
Positive Rotavirus Antigen	2 (1.85%)
High CRP (C-reactive protein) (>5 mg/dL)	16 (14.8%)
Complete blood count revealing anemia (hemoglobin < 12 g/dL, hematocrit < 35%)	17 (15.7%)
Hyperbilirubinemia (total serum bilirubin > 10 mg/dL)	14 (12.9%)

* MRSA—Methicillin-resistant Staphylococcus aureus. ** PCR—polymerase chain reaction.